source
- Federal court blocks mailing of mifepristoneLongevity "blue zones," an update on uterine transplant science, and more Morning Rounds health newsSTAT · 2mo ago↗ source
- STAT+: Biotech raises $42 million to run Huntington’s disease trialLatus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's disease.STAT · 2mo ago↗ source
- Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin withLabs are seeing fewer applications from international students and researchers, and some doctoral students are considering leaving early.STAT · 2mo ago↗ source